The COVID-19 lockdown has increased awareness of mental health issues – particularly clinical depression. However, clinical intervention relies on the individual presenting to...
The COVID-19 lockdown has increased awareness of mental health issues – particularly clinical depression. However, clinical intervention relies on the individual presenting to...
The Science Innovation Panel (SIP) is a new body set up under IHI to advise the Governing Board on a range of matters. In an interview with the IHI Programme Office, chair Anna...
The IMI-PainCare project has developed a new electrode to investigate pain perception in a clinical recreation of chronic pain, a condition which affects 1 in 5 Europeans.
The IMI AMYPAD project robustly assessed a numerical scale from 0-100 that can be used to quantitatively compare brain scans of Alzheimer’s patients. The method received a...
IHI is having impacts on the research ecosystem, on patients / health systems, and on Europe’s competitiveness.
Hitting the 200 project milestone shows the strength of the public-private partnership approach pioneered by the Innovative Medicines Initiative and built on by IHI.
After the outbreak of the COVID-19 pandemic in 2020, several projects including the CARE consortium were funded by IMI to investigate pandemic preparedness. We sat down for a chat...